Abstract:Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC We have previously developed the genetically-modified Salmonella typhimurium A1-R (A1-R) strain that selectively targets tumors and demonstrated its efficacy for various types of cancer cell lines in nude mouse models. The aim of this study is to determine the efficacy A1-R treatment for human-patient pancreatic tumorgrafts. Pancreatic-cancer-patient tumor specimens were initially established subcutaneously in NOD/SCID mice immediately after surgery. The patient tumors were then harvested from NOD/SCID mice and passed orthotopically in transgenic nude mice, expressing fluorescent protein in order for the tumors to acquire fluorescent stroma for imaging. After confirmation of tumor growth by fluorescence imaging, the nude mice were treated in the following groups: (1) 5-fluorouracil (5FU) (10 mg/kg, ip); (2) cisplatin (CDDP) (10 mg/kg, ip); (3) gemcitabine (GEM) (150 mg/kg, ip); (4) A1-R (A1-R) (1.5x108 cfu/body, ip); and (5) PBS (vehicle/control) (ip). Control, 5FU, CDDP, GEM and A1-R injections were performed on a weekly basis from day-21 after tumor implantation for 4 weeks. Animals were sacrificed at 7 weeks, and tumors were harvested for analysis. Each treatment arm involved 5 tumor-bearing mice. No significant effects on body weight, morbidity, or severe toxicities were observed in any treatment arm. The tumor weight of each group was as follows: (1) 5FU, 0.044 ± 0.027g; (2) CDDP, 0.04 ± 0.032g; (3) GEM, 0.058 ± 0.051g; (4) A1-R, 0.106 ± 0.038g; and (5) PBS, 0.258 ± 0.209g. S. typhimurium A1-R treatment significantly reduced the tumor weight compared to control treatment (p = 0.011), as did the other treatments including 5FU (p = 0.005), CDDP (p = 0.004), and GEM (p = 0.001). S. typhimurium A1-R treatment was effective for human pancreatic tumorgrafts and could be a promising therapy for human pancreatic cancer. Citation Format: Ming Zhao, Matthew H.G. Katz, Jason B. Fleming, Atsushi Suetsugu, Yong Zhang, Ali Maawy, Takashi Chishima, Kuniya Tanaka, Michael Bouvet, Yukihiko Hiroshima, Itaru Endo, Robert M. Hoffman. Efficacy of Salmonella typhimurium A1-R treatment on human patient pancreatic tumorgrafts. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3317. doi:10.1158/1538-7445.AM2013-3317

Abstract 3311: In vivo selection of S. typhimurium A1-R enhanced tumor-targeting variants.

Abstract 1691: A primer dose followed by low-bolus dose schedule of tumor-targeting ofS. typhimuriumA1-R is effective for tumor-targeted therapy

Abstract 5547: Oral delivery of tumor-targeting Salmonella typhimurium A1-R is effective therapeutically

Abstract 583: Treatment of human liver cancer in nude mice with a tumor-targeting<i>Salmonella typhimurium</i>auxotroph

Abstract 597: Bacteria targeting and tumor vascular destruction by<i>S. typhimurium</i>A1-R depend on the vascularity of the tumor site

The Efficacy Of Tumor-Targeting Salmonella Typhimurium A1-R On Bone Metastasis

A Primer Dose Followed By Low-Bolus Dose Schedule For Safe And Efficacious Bacterial Tumor Targeting With S. Typhimurium A1-R

Abstract 580: Bone marrow cells trafficking after<i>Salmonella typhimurium</i>A1-R tumor targeting

Abstract 3317: Efficacy of Salmonella typhimurium A1-R treatment on human patient pancreatic tumorgrafts.

Determination of the Optimal Route of Administration of Salmonella Typhimurium A1-R to Target Breast Cancer in Nude Mice

Abstract 2802: Salmonella typhimurium A1-R inhibits brain metastasis in an orthotropic breast cancer nude-mouse model.

Toxicology and Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R Compared to VNP 20009 in a Syngeneic Mouse Tumor Model in Immunocompetent Mice

Tumor‐Targeting Salmonella Typhimurium A1‐R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic‐Cancer Orthotopic Mouse Model

Primer Dosing of S. Typhimurium A1-R Potentiates Tumor-Targeting and Efficacy in Immunocompetent Mice.

Abstract 704: Comparison of Salmonella Typhimurium A1-R and VNP20009 on the Lewis Lung Carcinoma

Tumor-targeting Salmonella Typhimurium A1-R Prevents Experimental Human Breast Cancer Bone Metastasis in Nude Mice

Efficacy Against Lung Metastasis with a Tumor-Targeting Mutant of Salmonella Typhimurium in Immunocompetent Mice.

Therapeutic Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Human Colorectal Cancer Liver Metastasis in Orthotopic Nude-Mouse Models.

Abstract 4219: Surface-displayed RGD Enhanced the Targeting and Therapeutic Efficacy of Attenuated Salmonella Typhimurium

Abstract 709: Efficacy of Salmonella typhimurium A1-R on experimental breast cancer brain metastasis

Tumor-Targeting Salmonella Typhimurium A1-R Arrests Growth Of Breast-Cancer Brain Metastasis